Table 3.
Anti-oxidative and NF-kB inhibitory drugs used in preclinical/clinical studies
Drug/compound | Company | Status | Mode of Action |
---|---|---|---|
Antioxidants | |||
N-acetylcysteine (NAC) | *Twinlabs | Preclinical | Antioxidant |
Green tea extract (Epigallocatechin-Gallate; EGCg) | *Nature’s Way | Clinical trials | Antioxidant |
Melatonin | *GNC | Clinical trials | Antioxidant |
Idebenone | Santhera Pharmaceuticals | Clinical trials | Antioxidant |
NF-kB inhibition | |||
Remicade | Merck/Schering-Plough | Preclinical | Antibody to human TNF-α |
Etanercept | Wyeth | Preclinical | Blocks soluble receptor to TNF-α |
NBD peptide | **Enzo Life Science | Preclinical | Inhibitor of the NF-κB signaling pathway |
Available over the counter from several sources (e.g., NOW Foods, FoodScience of Vermont)
Clinical grade product not available